ANPI - Quotes - International Business Times

Angiotech due to collect royalties on stent

(VANCOUVER)Angiotech Pharmaceuticals said Friday its corporate partner Boston Scientific Corp. received approval for its Taxus Libert drug-coated stent, which had been delayed by federal regu...READ MORE

Today 5:27 PM EST

Keywords: BSX, ANPI

CombinatoRx 2Q loss grows on higher research costs

(CAMBRIDGE, Mass.)Biotech drug developer CombinatoRx Inc. said Wednesday its second-quarter loss widened as the company spent more money to develop its drug candidates Synavive and CRx-401 and reven...READ MORE

Aug 06, 2008 10:33AM

Keywords: CRXX, ANPI

Earnings roundup: Angiotech, Plum Creek Timber

Among the earnings stories for Monday, July 28, from AP Financial News: NEW YORK (AP)--Medical product maker Angiotech Pharmaceuticals Inc. reported a wider second-quarter loss Mon...READ MORE

Jul 28, 2008 7:56PM

Keywords: ANPI, PCL, PMD

Angiotech posts wider 2Q loss on research costs

(NEW YORK)Medical product maker Angiotech Pharmaceuticals Inc. reported a wider second-quarter loss Monday as its research and development costs grew. Angiotech posted a loss of $26.1 millio...READ MORE

Jul 28, 2008 2:43PM

Keywords: ANPI

Moody's puts Angiotech ratings on review

(NEW YORK)Moody's Investors Service said Wednesday it is reviewing ratings for Angiotech Pharmaceuticals Inc. and could possibly issue a downgrade, citing the medical product maker's negativ...READ MORE

Jul 02, 2008 2:22PM

Keywords: ANPI, BSX

Angiotech suspends enrollment in artery disease study

(NEW YORK)Medical device company Angiotech Pharmaceuticals Inc. said Monday it suspended patient enrollment in a study on its Vascular Wrap artery disease product because of safety concerns....READ MORE

Apr 21, 2008 8:28AM

Keywords: ANPI